SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Indo US Bio-Tech informs about company updates

16 Nov 2019 Evaluate

Indo Us Bio-Tech has informed that the Company has been awarded by BSE for being one of the top performers in SME Segment of BSE. The award has been received by Jagdish Ajudia, Managing Director of the Company from exchange officials at Diwali Muhurat Trading function and Felicitation of Top Volume Performers Programme of stock exchange held on October 27, 2019, at Mumbai. The Board of Directors and Top Management express sincere thanks for the same.

The above information is a part of company’s filings submitted to BSE.

Indo US Bio-Tech Share Price

108.00 -1.43 (-1.31%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Venkys India 1589.25
Mangalam Global Ent 12.93
Kaveri Seed 924.50
Regaal Resources 85.04
Simran Farms 165.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×